Results 111 to 120 of about 12,817 (217)
C형 간염 바이러스 NS5A 단백질의 인산화에 관한 연구
학위논문(석사) - 한국과학기술원 : 생물과학과, 1998.2, [ iv, 36 p. ]The genomic RNA of Hepatitis C virus (HCV) contains a single large open reading frame for virion Nonstructural polypeptides.
김지윤, Kim, Ji-Yun
core +1 more source
Conformational and binding properties of NS5A-D3 fragments.
(a). Amino acid sequence of NS5A-D3A, D3B and D3C. (b). Far-UV CD spectra of NS5A-D3 (blue), D3A (red), D3B (brown) and D3C (green). (c). Superimposition of 1H-15N NMR HSQC spectra of NS5A-D3A(394–447) in the absence of (black) and in the presence of ...
Haina Qin (143174) +2 more
core +1 more source
PI4KA interacts with NS5A in HCV-infected cells.
(A) Schematic of the Jc1(SF) viral genome containing a tandem Strep-tag II and a FLAG tag in domain III of NS5A. (B) Productive infection of hepatoma cells with the Jc1(SF) virus. Huh7.5.1 cells were infected with wild-type Jc1 (upper panels) and culture-
Shadi Salloum (342115) +1 more
core +1 more source
Effects of HCV Protein NS5A on Antiviral Gene Expression
Hepatitis C virus (HCV) currently infects about 170 million people worldwide. HCV protein NS5A is a known inhibitor of the host innate immune response, specifically, the IFN-b production pathway.
Taetz, Sarah
core
GPS2 interacts and colocalizes with NS5A.
(A) GPS2 interacts with NS5A in transfected cells. 293T cells (2×106) were transfected with the indicated plasmids (6 µg each). Cell lysates were immunoprecipitated with anti-Flag (F) antibody or control mouse IgG (Ig).
Xiu Xin (479782) +2 more
core +1 more source
Ombitasvir (ABT-267), a novel NS5A inhibitor for the treatment of hepatitis C
INTRODUCTION: Chronic hepatitis C infection is a global disease with 160 million people infected worldwide. Until recently, therapy was characterized by long duration, suboptimal success rates and significant adverse drug reactions.
Stirnimann, Guido
core +1 more source
BMS-Biotin does not compete for LDV binding to NS5A.
(A) Huh7-lunet cells were transfected with pTK-NS5A. 24 hr post transfection, cells were treated for 42 hr with a fixed concentration of BMS-Biotin and increasing concentrations of LDV or DCV.
Katherine M. Brendza (158359) +10 more
core +1 more source
Background Data on persistence of NS5A resistance-associated substitutions (RASs) may have implications for resistance testing approaches and selection of initial and retreatment strategies. Methods Long-term persistence of NS5A RASs in HCV genotype (GT)
Hongmei Mo +13 more
core +1 more source
PC interacts and colocalizes with the HCV NS5A protein.
PC interacts with NS5A derived from both genotype 1b and 2a. Either Huh7.5 cells (A) or HEK293T cells (B) were cotransfected with Myc-tagged NS5A of genotype 1b or 2a in the absence or presence of Flag-tagged PC.
Yun-Sook Lim (157976) +3 more
core +1 more source
Introduction and Objectives: Liver fibrosis remains a complication derived from a chronic Hepatitis C Virus (HCV) infection even when it is resolved, and no liver antifibrotic drug has been approved.
Tania G. Heredia-Torres +6 more
doaj +1 more source

